Mount Sinai, The Tisch Cancer Instutute — New York, New York

Mount Sinai, The Tisch Cancer Instutute is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai, The Tisch Cancer Instutute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma, Plasma Cell Disorder.

Sponsors: Heidelberg Pharma AG.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai, The Tisch Cancer Instutute?

Mount Sinai, The Tisch Cancer Instutute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai, The Tisch Cancer Instutute conducted?

Mount Sinai, The Tisch Cancer Instutute has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Plasma Cell Disorder.

Is Mount Sinai, The Tisch Cancer Instutute accredited by Crixeo Health?

Mount Sinai, The Tisch Cancer Instutute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai, The Tisch Cancer Instutute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.